Develops, manufactures and distributes disposable and implantable vascular devices as well as human tissue allograft material for vascular surgery.

LeMaitre Vascular, Inc.

Burlington, MA (US) · Sulzbach/Ts. (DE) · Singapore (SG) · Mississauga, ON (CA) · Dublin (IE) · Hereford (GB) · Madrid (ES) · Maisons-Alfort (FR) · Glattbrugg/Opfikon (CH) · Milan (IT) · BangkokNew on Amplifa

1983Founded (as Vascutech)

160+Sales representatives worldwide (as of 01.05.2025)

90+countries supplied; direct sales in 31, distributors in

NASDAQpublicly listed (IPO 2006)

180,000+valvulotome units sold in the last 10 years

About LeMaitre

LeMaitre (until 2021 LeMaitre Vascular) is a globally active manufacturer of disposable and implantable medical devices as well as services for the treatment of peripheral vascular disease. Founded in 1983 by vascular surgeon George D. LeMaitre and headquartered in Burlington, Massachusetts (USA), the company produces, among other things, the valvulotome, embolectomy catheters, occlusion catheters, vascular patches and collagen vascular prostheses. Through the RestoreFlow Allografts division, cryopreserved human vascular allografts (saphenous vein, femoral artery, aortoiliac arteries) are also processed, stored and distributed. The products are used in open vascular surgery and minimally invasive procedures, in particular for peripheral bypasses, dialysis access and the treatment of aortic infections. LeMaitre supplies over 90 countries, 31 of them via direct sales with more than 160 sales representatives and over 65 countries through distributors. The headquarters is located in Burlington (USA); the European center of LeMaitre Vascular GmbH is in Sulzbach/Ts. near Frankfurt am Main, and the Asia-Pacific center is in Singapore. The company is listed on the NASDAQ.

Site: Sulzbach/Ts.
Processes: Tissue processing (RestoreFlow Allografts), Manufacturing of disposable and implantable vascular devices, Surgeon training, Product training, 24/7 donor screening and tissue recovery support, Distribution via direct sales and distributors
Materials: Cryopreserved human vascular tissue, Biological and biosynthetic patches, Collagen vascular graft (Artegraft)
Certificates: AATB accreditation (cardiac/tissue: Processing, Donor Screening, Storage,, AATB accreditation (Processing, Donor Screening, Storage, Distribution)
Founded: 1983
Industries: Medical technology, Vascular surgery, Peripheral vascular disease, Cardiovascular medicine, Cardiac and vascular tissue allografts

01
Product development (R&D)
02
Manufacturing of disposable and implantable vascular devices
03
Tissue processing (RestoreFlow Allografts)
04
Packaging/sterilization
05
Distribution via direct sales and distributors
06
Product training and surgeon training

Products and Processes

Allograft

Cryopreserved human vascular tissue

Saphenous vein, femoral artery and aortoiliac allografts as an alternative to autologous conduit or synthetic prostheses.

Biologic Patch

Biological and biosynthetic patches

XenoSure, CardioCel/VascuCel and Omniflow for vascular reconstructions.

Collagen Graft

Collagen vascular graft (Artegraft)

Collagen vascular prosthesis for vascular access and reconstructions.

Locations

Burlington, MA

Corporate Headquarters

Sulzbach/Ts.

Europe Headquarters (LeMaitre Vascular GmbH)

Singapore

Asia Pacific Headquarters (LeMaitre Pte. Ltd.)

Fox River Grove, IL

RestoreFlow Allograft Distribution / Tissue Processing

Materials: Human vascular tissue

Biologics cleanroom (since 2017)

Hereford

UK Sales Office / RestoreFlow Allograft Distribution

Vaughan, ON

RestoreFlow Allograft Distribution

Products

**RestoreFlow Saphenous Vein Allograft**Cryopreservation · Vascular surgery

**RestoreFlow Femoral Artery Allograft**Cryopreservation · Vascular surgery

**RestoreFlow Aortoiliac Allograft**Cryopreservation · Vascular surgery

Inside the production

Global presence: locations and distributors

Industries

Medical technologyVascular surgeryPeripheral vascular diseaseCardiovascular medicineCardiac and vascular tissue allografts

Additional services

Tissue processing (RestoreFlow Allografts)Manufacturing of disposable and implantable vascular devicesSurgeon trainingProduct training24/7 donor screening and tissue recovery supportDistribution via direct sales and distributors

Reference customers

UPMC Altoona, Pennsylvania (Dr. Nicholas Madden)Summa Health Akron City Hospital, Ohio (Dr. McShannic)Bryan C. Kramer, MD

Quality and Accreditations

LeMaitre pursues a quality policy (QM9.0) that places regulatory compliance, continuous improvement and product safety at its center. The tissue processing facility in Fox River Grove, IL is accredited by the American Association of Tissue Banks (AATB) for the processing, storage and distribution of cardiovascular and vascular tissue.

Evidence	Fox River Grove, IL
AATB accreditation (Processing, Donor Screening, Storage, Distribution)

History

1983
Vascutech is founded by George D. LeMaitre, MD
1985
First valvulotome is sold
1992
George W. LeMaitre joins Vascutech
1997
European Headquarters opens in Frankfurt, Germany
2001
Acquisition of Ideas for Medicine including the Pruitt Carotid Shunt; name change to LeMaitre Vascular
2004
Asian Headquarters opens in Tokyo; acquisition of the AnastoClip Closure System from U.S. Surgical
2006
Initial Public Offering on the NASDAQ
2012
Acquisition of the XenoSure Biologic Patch from Neovasc
2014
Acquisition of the Omniflow Biosynthetic Graft from Xenotis; sales buildup in Australia; sales office in Shanghai
2017
Dedicated biologics cleanroom opens
2018
Asia Pacific Headquarters relocates to Singapore
2019
Acquisition of the CardioCel and VascuCel patches from Admedus
2020
Acquisition of the Artegraft Collagen Vascular Graft
2021
Rebranding from LeMaitre Vascular to LeMaitre
2023
40 years serving the vascular community